🔗 Share this article

This year's Nobel Prize in Physiology or Medicine has been granted for revolutionary discoveries that illuminate how the body's defense network attacks dangerous infections while sparing the body's own cells.

Three renowned researchers—from Japan Prof. Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

The research identified specialized "security guards" within the immune system that remove malfunctioning immune cells capable of attacking the organism.

The findings are now paving the way for innovative treatments for immune disorders and malignancies.

The winners will share a prize fund worth 11m Swedish kronor.

Decisive Findings

"Their work has been essential for comprehending how the body's defenses functions and why we don't all suffer from severe autoimmune diseases," stated the head of the Nobel Committee.

This team's studies address a fundamental question: In what way does the defense system protect us from countless invaders while leaving our healthy cells intact?

Our body's protection system uses white blood cells that search for indicators of infection, even viruses and germs it has never encountered.

These cells utilize sensors—called recognition units—that are produced randomly in a vast number of variations.

That gives the defense network the capacity to combat a broad range of threats, but the unpredictability of the mechanism unavoidably creates immune cells that can target the body.

Protectors of the Immune System

Scientists previously understood that a portion of these problematic white blood cells were destroyed in the thymus—where white blood cells mature.

This year's award honors the discovery of T-reg cells—known as the immune system's "peacekeepers"—which travel through the system to disarm any defenders that assault the body's own tissues.

It is known that this process fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "These discoveries have laid the foundation for a novel area of research and accelerated the creation of innovative treatments, for instance for cancer and immune disorders."

In malignancies, T-regs block the system from attacking the tumor, so research are focused on reducing their quantity.

For self-attack disorders, experiments are testing increasing regulatory T-cells so the body is not being harmed. A comparable approach could also be effective in reducing the chances of organ transplant failure.

Pioneering Experiments

Prof Shimon Sakaguchi, from Osaka University, conducted tests on rodents that had their immune gland extracted, causing self-attack conditions.

The researcher demonstrated that introducing immune cells from other animals could stop the disease—suggesting there was a mechanism for preventing defenders from harming the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, currently at a biotech firm in a California city, were investigating an inherited autoimmune disease in mice and people that led to the discovery of a gene vital for the way regulatory T-cells operate.

"The groundbreaking research has revealed how the immune system is kept in check by regulatory T cells, stopping it from mistakenly attacking the body's own tissues," commented a prominent physiology expert.

"The research is a remarkable illustration of how fundamental biological research can have broad implications for human health."